Epithalon Preclinical Safety Profile: What the Literature Reports
This literature review synthesizes published preclinical safety, toxicity, and tolerability data for Epithalon (Ala-Glu-Asp-Gly), a synthetic pineal bioregulator peptide. Designed strictly for analytical and laboratory evaluation, this overview outlines acute and chronic observational parameters across animal models, cytotoxicity assays, and standard laboratory safety handling procedures.
Quick answer
This literature review synthesizes published preclinical safety, toxicity, and tolerability data for Epithalon (Ala-Glu-Asp-Gly), a synthetic pineal bioregulator peptide. Designed strictly for analytical and laboratory evaluation, this overview outlines acute and chronic observational parameters across animal models, cytotoxicity assays, and standard laboratory safety handling procedures.
Key takeaways
- [Epithalon](/research-peptides/epithalon) (also known as Epitalon) is a synthetic tetrapeptide with the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-glycine (Ala-Glu-Asp-Gly).
- Preclinical toxicology studies investigating [Epithalon](/research-peptides/epithalon) across acute exposure paradigms have consistently demonstrated a high threshold of biological tolerability in animal models.
- Long-term observational studies extending across the lifespan of rodent models have evaluated the cumulative physiological impacts of chronic [Epithalon](/research-peptides/epithalon) administration.
- Laboratory safety assessments frequently analyze clinical chemistry and hematology panels in animal models subjected to peptide bioregulator protocols.
Introduction to Epithalon and Bioregulator Research
Epithalon (also known as Epitalon) is a synthetic tetrapeptide with the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-glycine (Ala-Glu-Asp-Gly). Developed as a short-chain mimetic of pineal gland extract (epithalamin), Epithalon belongs to a class of short peptide bioregulators studied for their ability to interact with chromatin structure and regulate gene expression at the transcriptional level.
In basic biological models, Epithalon is primarily investigated for its role in telomerase activation, telomere length maintenance, and the regulation of pineal-dependent circadian biological rhythms. To support rigorous laboratory research, PX1 Research provides high-purity Epithalon verified via advanced analytical methodology. Researchers evaluating peptide bioregulators can browse our complete catalog of all peptides for comparative structural analysis.
Acute Toxicity and LD50 Findings in Preclinical Models
Preclinical toxicology studies investigating Epithalon across acute exposure paradigms have consistently demonstrated a high threshold of biological tolerability in animal models. Standard acute toxicity protocols in rodent models (including standard laboratory mice and Wistar rats) evaluated single-dose administrations across ranges far exceeding standard laboratory trial concentrations.
In published rodent trials, researchers reported no median lethal dose (LD50) achievable within the practical limits of aqueous solubility. Doses administered up to several thousand times higher than baseline experimental targets produced no observable acute mortality, respiratory distress, behavioral alterations, or gross pathological changes upon necropsy. These findings in rodent models indicate that the short tetrapeptide sequence exhibits low acute systemic toxicity in experimental animal systems.
Subchronic and Chronic Tolerability in Animal Models
Long-term observational studies extending across the lifespan of rodent models have evaluated the cumulative physiological impacts of chronic Epithalon administration. In long-term rodent cohorts (including aging female mice and rats), recurring exposure cycles did not produce histopathological tissue damage or toxic organ accumulation.
Necropsy and histological evaluations of major organ systems—including cardiac, hepatic, renal, and splenic tissues—demonstrated intact cellular architecture without evidence of tissue necrosis, chronic inflammation, or degenerative lesions. In non-human primate observational models (such as aging *Macaca mulatta*), long-term administration schedules were similarly monitored without evidence of severe adverse physical reactions, weight loss, or chronic systemic stress.
Biochemical and Hematological Parameters
Laboratory safety assessments frequently analyze clinical chemistry and hematology panels in animal models subjected to peptide bioregulator protocols. Published data from rodent and primate assays indicate that Epithalon exposure does not destabilize baseline hematological parameters.
Complete blood counts (CBC) remained within standard physiological ranges, with no significant deviations in erythrocyte counts, leukocyte differentials, or platelet concentrations. Hepatic biomarker assays evaluating serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) demonstrated no compound-induced hepatotoxicity. Similarly, renal function markers, including blood urea nitrogen (BUN) and creatinine, remained steady throughout multi-month observation periods, indicating preserved filtration integrity in animal models.
In Vitro Cytotoxicity, Genotoxicity, and Mutagenicity Data
To establish safety at the cellular level, Epithalon has undergone evaluation in standardized *in vitro* assay systems. Bacterial reverse mutation assays (Ames testing using *Salmonella typhimurium* strains) were conducted to assess genotoxic potential. Results across tested strains consistently demonstrated no induction of gene mutations or mutagenic activity in the presence or absence of metabolic activation systems.
In eukaryotic cell culture models, including human fetal fibroblast cultures and isolated lymphocyte assays, Epithalon demonstrated absence of cytotoxicity at standard micromolar culture concentrations. Cell viability assays (such as MTT and LDH release assays) showed maintained membrane integrity and proliferative potential. Chromosomal aberration tests in cultured mammalian cells further confirmed an absence of structural or numerical clastogenic events under experimental conditions.
Comparative Safety Profile Across Related Research Peptides
Evaluating Epithalon within the broader context of peptide bioregulators highlights key structural and functional distinctions. Short synthetic peptides generally exhibit lower immunogenic profiles than larger protein therapeutics due to their low molecular weight and rapid enzymatic clearance.
For instance, Pinealon—a tripeptide bioregulator (Glu-Asp-Arg) focused on central nervous system models—exhibits similar low-toxicity profiles in rodent assays. Similarly, Thymalin, a thymic peptide complex evaluated for immunomodulatory pathways, shares a high safety margin in animal models, though its complex composition requires distinct analytical oversight compared to pure short-chain synthetics. Non-bioregulator research molecules such as GHK-Cu involve chelated copper dynamics requiring specific concentration monitoring to avoid localized cellular stress. Epithalon's simple tetrapeptide backbone minimizes cellular accumulation risks while offering high baseline stability in research assays.
Analytical Quality Control, Purity, and Endotoxin Standards at PX1 Research
When conducting epithalon safety research, experimental outcomes depend entirely on the purity and chemical integrity of the reagent. Impurities such as residual synthesis reagents, TFA (trifluoroacetic acid) salts, and bacterial endotoxins can cause confounding cellular stress or inflammatory responses in *in vitro* and animal models, misrepresenting compound toxicity.
PX1 Research enforces strict quality control standards for all benchtop compounds. Every lot is USA-manufactured in GMP-compliant facilities and undergoes rigorous testing in an ISO 17025 accredited laboratory. Purity is validated to exceed 99% via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Furthermore, every batch undergoes Chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly controlled below strict research thresholds. Researchers can inspect batch-specific documentation by reviewing our official Certificate of Analysis (COA) repository.
Reconstitution Parameters and In Vitro Handling
Epithalon is supplied as a lyophilized sterile powder to maintain long-term peptide stability. For laboratory preparation, reconstitution should be performed using Sterile Bacteriostatic Water or Sterile Phosphate-Buffered Saline (PBS, pH 7.4) under a laminar flow hood.
Care should be taken to avoid vigorous agitation; gentle swirling is recommended to prevent shear stress on the peptide structure. To calculate precise volumetric concentrations and stock dilutions for cell culture or assay preparation, researchers should utilize our interactive reconstitution calculator. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles and stored at -20°C or -80°C for optimal physical stability.
Laboratory Handling, Chemical Safety, and SDS Protocols
While Epithalon exhibits low biological toxicity in preclinical models, standard laboratory chemical hygiene protocols must be strictly maintained by all laboratory personnel handling raw or reconstituted material.
Personnel must wear appropriate Personal Protective Equipment (PPE), including nitrile gloves, laboratory coats, and safety goggles. In the event of an accidental benchtop spill, absorb the liquid with inert material, clean the surface with a 70% ethanol solution, and dispose of generated waste in designated hazardous biochemical containers. Avoid inhalation of lyophilized powder by performing all mass measurements inside a certified chemical fume hood or biosafety cabinet. For complete hazard identification, physical properties, and disposal guidance, consult the official Epithalon Safety Data Sheet (SDS). Institutional researchers acquiring materials for high-throughput screens can set up commercial terms through our wholesale lab portal.
Frequently Asked Questions
What is the primary focus of epithalon safety research in literature?
Epithalon safety research in published literature focuses on establishing acute LD50 thresholds, evaluating chronic tissue tolerability, screening for immunogenicity, and verifying the absence of mutagenicity in cell line models and animal systems.
Has Epithalon demonstrated cytotoxicity in in vitro assays?
Published in vitro data indicate that Epithalon does not induce cytotoxicity or membrane disruption in standard mammalian cell lines (such as human fibroblasts) at typical micromolar experimental concentrations.
What toxicological markers are measured in Epithalon animal studies?
Preclinical studies typically measure serum liver enzymes (ALT, AST, ALP), renal function indicators (BUN, creatinine), complete blood counts (CBC), and conduct post-mortem histopathology on organ tissues.
How does PX1 Research ensure the chemical purity of Epithalon?
PX1 Research verifies compound identity and purity (>99%) using HPLC and Mass Spectrometry in ISO 17025 accredited facilities. Every lot is accompanied by a publicly verifiable Certificate of Analysis (COA).
Why is endotoxin testing critical for Epithalon research reagents?
Bacterial endotoxins (LPS) can trigger inflammatory signaling cascades in cell cultures and animal models, confounding experimental results. PX1 subjects all batches to LAL assay testing to enforce low endotoxin limits.
What solvent is recommended for Epithalon reconstitution?
Epithalon is readily soluble in aqueous media, such as sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), under standard laboratory protocol.
What PPE is required when handling lyophilized Epithalon powder?
Laboratory personnel should wear safety glasses, lab coats, and nitrile gloves. Dust mask or biosafety hood usage is recommended when weighing unconstituted powder to prevent accidental inhalation.
How should reconstituted Epithalon stock solutions be stored?
Reconstituted solutions should be aliquoted into sterile microcentrifuge tubes to avoid freeze-thaw degradation and stored at -20°C or -80°C for long-term preservation.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.